Arkansas Legal Resource Navigator

21 U.S.C. § 387j — Application for review of certain tobacco products

Federal law — U.S. Code and appendices · legal_authorities

21 U.S.C. § 387j — Application for review of certain tobacco products

**(a) In general** (1) **New tobacco product defined** — For purposes of this section the term “new tobacco product” means— (A) any tobacco product (including those products in test markets) that was not commercially marketed in the United States as of February 15, 2007; or (B) any modification (including a change in design, any component, any part, or any constituent, including a smoke constituent, or in the content, delivery or form of nicotine, or any other additive or ingredient) of a tobacco product where the modified product was commercially marketed in the United States after February 15, 2007. (2) **Premarket review required** (A) *New products* — An order under subsection (c)(1)(A)(i) for a new tobacco product is required unless— (i) the manufacturer has submitted a report under [section 387e(j) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section387e/j&num=0&edition=prelim); and the Secretary has issued an order that the tobacco product— (I) is substantially equivalent to a tobacco product commercially marketed (other than for test marketing) in the United States as of February 15, 2007; and (II) is in compliance with the requirements of this chapter; or (ii) the tobacco product is exempt from the requirements of [section 387e(j) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section387e/j&num=0&edition=prelim) pursuant to a regulation issued under [section 387e(j)(3) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section387e/j/3&num=0&edition=prelim). (B) *Application to certain post-February 15, 2007, products* — Subparagraph (A) shall not apply to a tobacco product— (i) that was first introduced or deliv

Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 387j

Stored review status: release_metadata_unconfirmed. A text match is a research starting point; applicability is not established.

Original supplied file — preserved unchanged

Download original Markdown file

File SHA-256: 4555960d88435a43c48a46bb47d35e79e1444c69c421ca70d0c35b2c40e82dbc. The original may include catalog metadata, neighboring provisions, or embedded records outside this collection's scope. Search shows only the selected federal record. Historical editions and unverified snapshots are not a statement of current law.

Authority boundary: historical or unconfirmed source not current law verified.

Open the recorded source website ↗

Record provenance

Stable record: federal_law:legal_authorities:record_usc_08afbe3738bfcad6cf130b96
Source file: Laws/federal/codes/united-states-code/title-21/section-387j-application-for-review-of-certain-tobacco-products--fa282e7c92.md
Pages: Not recorded – Not recorded
Passage SHA-256: c5d12453a86a8528ad70e4154718333ff9979f0e19fef8601239d2bec1f0ed6b

Source location: Title 21, Chapter 9, § 387j; chapter-009-federal-food-drug-and-cosmetic-act.md

Stored source content

**(a) In general** (1) **New tobacco product defined** — For purposes of this section the term “new tobacco product” means— (A) any tobacco product (including those products in test markets) that was not commercially marketed in the United States as of February 15, 2007; or (B) any modification (including a change in design, any component, any part, or any constituent, including a smoke constituent, or in the content, delivery or form of nicotine, or any other additive or ingredient) of a tobacco product where the modified product was commercially marketed in the United States after February 15, 2007. (2) **Premarket review required** (A) *New products* — An order under subsection (c)(1)(A)(i) for a new tobacco product is required unless— (i) the manufacturer has submitted a report under [section 387e(j) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section387e/j&num=0&edition=prelim); and the Secretary has issued an order that the tobacco product— (I) is substantially equivalent to a tobacco product commercially marketed (other than for test marketing) in the United States as of February 15, 2007; and (II) is in compliance with the requirements of this chapter; or (ii) the tobacco product is exempt from the requirements of [section 387e(j) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section387e/j&num=0&edition=prelim) pursuant to a regulation issued under [section 387e(j)(3) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section387e/j/3&num=0&edition=prelim). (B) *Application to certain post-February 15, 2007, products* — Subparagraph (A) shall not apply to a tobacco product— (i) that was first introduced or delivered for introduction into interstate commerce for commercial distribution in the United States after February 15, 2007, and prior to the date that is 21 months after June 22, 2009; and (ii) for which a report was submitted under [section 387e(j) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section387e/j&num=0&edition=prelim) within such 21-month period, except that subparagraph (A) shall apply to the tobacco product if the Secretary issues an order that the tobacco product is not substantially equivalent. (3) **Substantially equivalent defined** (A) *In general* — In this section and [section 387e(j) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section387e/j&num=0&edition=prelim), the term “substantially equivalent” or “substantial equivalence” means, with respect to the tobacco product being compared to the predicate tobacco product, that the Secretary by order has found that the tobacco product— (i) has the same characteristics as the predicate tobacco product; or (ii) has different characteristics and the information submitted contains information, including clinical data if deemed necessary by the Secretary, that demonstrates that it is not appropriate to regulate the product under this section because the product does not raise different questions of public health. (B) *Characteristics* — In subparagraph (A), the term “characteristics” means the materials, ingredients, design, composition, heating source, or other features of a tobacco product. (C) *Limitation* — A tobacco product may not be found to be substantially equivalent to a predicate tobacco product that has been removed from the market at the initiative of the Secretary or that has been determined by a judicial order to be misbranded or adulterated. (4) **Health information** (A) *Summary* — As part of a submission under [section 387e(j) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section387e/j&num=0&edition=prelim) respecting a tobacco product, the person required to file a premarket notification under such section shall provide an adequate summary of any health information related to the tobacco product or state that such information will be made available upon request by any person. (B) *Required information* — Any summary under subparagraph (A) respecting a tobacco product shall contain detailed information regarding data concerning adverse health effects and shall be made available to the public by the Secretary within 30 days of the issuance of a determination that such tobacco product is substantially equivalent to another tobacco product. **(b) Application** (1) **Contents** — An application under this section shall contain— (A) full reports of all information, published or known to, or which should reasonably be known to, the applicant, concerning investigations which have been made to show the health risks of such tobacco product and whether such tobacco product presents less risk than other tobacco products; (B) a full statement of the components, ingredients, additives, and properties, and of the principle or principles of operation, of such tobacco product; (C) a full description of the methods used in, and the facilities and controls used for, the manufacture, processing, and, when relevant, packing and installation of, such tobacco product; (D) an identifying reference to any tobacco product standard under [section 387g of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section387g&num=0&edition=prelim) which would be applicable to any aspect of such tobacco product, and either adequate information to show that such aspect of such tobacco product fully meets such tobacco product standard or adequate information to justify any deviation from such standard; (E) such samples of such tobacco product and of components thereof as the Secretary may reasonably require; (F) specimens of the labeling proposed to be used for such tobacco product; and (G) such other information relevant to the subject matter of the application as the Secretary may require. (2) **Referral to Tobacco Products Scientific Advisory Committee** — Upon receipt of an application meeting the requirements set forth in paragraph (1), the Secretary— (A) may, on the Secretary’s own initiative; or (B) may, upon the request of an applicant, refer such application to the Tobacco Products Scientific Advisory Committee for reference and for submission (within such period as the Secretary may establish) of a report and recommendation respecting the application, together with all underlying data and the reasons or basis for the recommendation. **(c) Action on application** (1) **Deadline** (A) *In general* — As promptly as possible, but in no event later than 180 days after the receipt of an application under subsection (b), the Secretary, after considering the report and recommendation submitted under subsection (b)(2), shall— (i) issue an order that the new product may be introduced or delivered for introduction into interstate commerce if the Secretary finds that none of the grounds specified in paragraph (2) of this subsection applies; or (ii) issue an order that the new product may not be introduced or delivered for introduction into interstate commerce if the Secretary finds (and sets forth the basis for such finding as part of or accompanying such denial) that 1 or more grounds for denial specified in paragraph (2) of this subsection apply. (B) *Restrictions on sale and distribution* — An order under subparagraph (A)(i) may require that the sale and distribution of the tobacco product be restricted but only to the extent that the sale and distribution of a tobacco product may be restricted under a regulation under [section 387f(d) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section387f/d&num=0&edition=prelim). (2) **Denial of application** — The Secretary shall deny an application submitted under subsection (b) if, upon the basis of the information submitted to the Secretary as part of the application and any other information before the Secretary with respect to such tobacco product, the Secretary finds that— (A) there is a lack of a showing that permitting such tobacco product to be marketed would be appropriate for the protection of the public health; (B) the methods used in, or the facilities or controls used for, the manufacture, processing, or packing of such tobacco product do not conform to the requirements of [section 387f(e) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section387f/e&num=0&edition=prelim); (C) based on a fair evaluation of all material facts, the proposed labeling is false or misleading in any particular; or (D) such tobacco product is not shown to conform in all respects to a tobacco product standard in effect under [section 387g of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section387g&num=0&edition=prelim), and there is a lack of adequate information to justify the deviation from such standard. (3) **Denial information** — Any denial of an application shall, insofar as the Secretary determines to be practicable, be accompanied by a statement informing the applicant of the measures required to remove such application from deniable form (which measures may include further research by the applicant in accordance with 1 or more protocols prescribed by the Secretary). (4) **Basis for finding** — For purposes of this section, the finding as to whether the marketing of a tobacco product for which an application has been submitted is appropriate for the protection of the public health shall be determined with respect to the risks and benefits to the population as a whole, including users and nonusers of the tobacco product, and taking into account— (A) the increased or decreased likelihood that existing users of tobacco products will stop using such products; and (B) the increased or decreased likelihood that those who do not use tobacco products will start using such products. (5) **Basis for action** (A) *Investigations* — For purposes of paragraph (2)(A), whether permitting a tobacco product to be marketed would be appropriate for the protection of the public health shall, when appropriate, be determined on the basis of well-controlled investigations, which may include 1 or more clinical investigations by experts qualified by training and experience to evaluate the tobacco product. (B) *Other evidence* — If the Secretary determines that there exists valid scientific evidence (other than evidence derived from investigations described in subparagraph (A)) which is sufficient to evaluate the tobacco product, the Secretary may authorize that the determination for purposes of paragraph (2)(A) be made on the basis of such evidence. **(d) Withdrawal and temporary suspension** (1) **In general** — The Secretary shall, upon obtaining, where appropriate, advice on scientific matters from the Tobacco Products Scientific Advisory Committee, and after due notice and opportunity for informal hearing for a tobacco product for which an order was issued under subsection (c)(1)(A)(i), issue an order withdrawing the order if the Secretary finds— (A) that the continued marketing of such tobacco product no longer is appropriate for the protection of the public health; (B) that the application contained or was accompanied by an untrue statement of a material fact; (C) that the applicant— (i) has failed to establish a system for maintaining records, or has repeatedly or deliberately failed to maintain records or to make reports, required by an applicable regulation under [section 387i of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section387i&num=0&edition=prelim); (ii) has refused to permit access to, or copying or verification of, such records as required by [section 374 of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section374&num=0&edition=prelim); or (iii) has not complied with the requirements of [section 387e of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section387e&num=0&edition=prelim); (D) on the basis of new information before the Secretary with respect to such tobacco product, evaluated together with the evidence before the Secretary when the application was reviewed, that the methods used in, or the facilities and controls used for, the manufacture, processing, packing, or installation of such tobacco product do not conform with the requirements of [section 387f(e) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section387f/e&num=0&edition=prelim) and were not brought into conformity with such requirements within a reasonable time after receipt of written notice from the Secretary of nonconformity; (E) on the basis of new information before the Secretary, evaluated together with the evidence before the Secretary when the application was reviewed, that the labeling of such tobacco product, based on a fair evaluation of all material facts, is false or misleading in any particular and was not corrected within a reasonable time after receipt of written notice from the Secretary of such fact; or (F) on the basis of new information before the Secretary, evaluated together with the evidence before the Secretary when such order was issued, that such tobacco product is not shown to conform in all respects to a tobacco product standard which is in effect under [section 387g of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section387g&num=0&edition=prelim), compliance with which was a condition to the issuance of an order relating to the application, and that there is a lack of adequate information to justify the deviation from such standard. (2) **Appeal** — The holder of an application subject to an order issued under paragraph (1) withdrawing an order issued pursuant to subsection (c)(1)(A)(i) may, by petition filed on or before the 30th day after the date upon which such holder receives notice of such withdrawal, obtain review thereof in accordance with section 387l of this title. (3) **Temporary suspension** — If, after providing an opportunity for an informal hearing, the Secretary determines there is reasonable probability that the continuation of distribution of a tobacco product under an order would cause serious, adverse health consequences or death, that is greater than ordinarily caused by tobacco products on the market, the Secretary shall by order temporarily suspend the authority of the manufacturer to market the product. If the Secretary issues such an order, the Secretary shall proceed expeditiously under paragraph (1) to withdraw such application. **(e) Service of order** An order issued by the Secretary under this section shall be served— (1) in person by any officer or employee of the department designated by the Secretary; or (2) by mailing the order by registered mail or certified mail addressed to the applicant at the applicant’s last known address in the records of the Secretary. **(f) Records** (1) **Additional information** — In the case of any tobacco product for which an order issued pursuant to subsection (c)(1)(A)(i) for an application filed under subsection (b) is in effect, the applicant shall establish and maintain such records, and make such reports to the Secretary, as the Secretary may by regulation, or by order with respect to such application, prescribe on the basis of a finding that such records and reports are necessary in order to enable the Secretary to determine, or facilitate a determination of, whether there is or may be grounds for withdrawing or temporarily suspending such order. (2) **Access to records** — Each person required under this section to maintain records, and each person in charge of custody thereof, shall, upon request of an officer or employee designated by the Secretary, permit such officer or employee at all reasonable times to have access to and copy and verify such records. **(g) Investigational tobacco product exemption for investigational use** The Secretary may exempt tobacco products intended for investigational use from the provisions of this subchapter under such conditions as the Secretary may by regulation prescribe.

Cross-references

Connections may be documented source relationships, shared citations or nearby passages. Each explains its basis; a connection alone does not establish applicability to your situation.

Federal law — U.S. Code and appendices · legal_authorities

21 U.S.C. § 399a — Office of the Chief Scientist

**(a) Establishment; appointment** The Secretary shall establish within the Office of the Commissioner an office to be known as the Office of the Chief Scientist. The Secretary shall appoint a Chief Scientist to lead such Office. **(b) Duties of the Office** The Office of the Chief Scientist shall— (1) oversee, coordinate, and ensure quality and regulatory focus of the intramural research programs of the Food and Drug Administration; (2) track and, to the extent necessary, coordinate intramural research awards made by each center of the Administration or science-based office within the Office of the Commissioner, and ensure that there is no duplication of research efforts supported by the Reagan-Udall Foundation for the Food and Drug Administration; (3) develop and advocate for a budget to support intramural research; (4) develop a peer review process by which intramural research can be evaluated; (5) identify and solicit intramural research proposals from across the Food and Drug Administration through an advisory board composed of employees of the Administration that shall include— (A) representatives of each of the centers and the science-based offices within the Office of the Commissioner; and (B) experts on trial design, epidemiology, demographics, pharmacovigilance, basic science, and public health; and (6) develop postmarket safety performance measures that are as measurable and rigorous as the ones already developed for premarket review.

Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 399a

Stored review status: release_metadata_unconfirmed. Explicit cross-reference supplied in source Markdown; currentness and applicability require review.

Federal law — U.S. Code and appendices · legal_authorities

21 U.S.C. § 387g — Tobacco product standards

**(a) In general** (1) **Special rules** (A) *Special rule for cigarettes* — Beginning 3 months after June 22, 2009, a cigarette or any of its component parts (including the tobacco, filter, or paper) shall not contain, as a constituent (including a smoke constituent) or additive, an artificial or natural flavor (other than tobacco or menthol) or an herb or spice, including strawberry, grape, orange, clove, cinnamon, pineapple, vanilla, coconut, licorice, cocoa, chocolate, cherry, or coffee, that is a characterizing flavor of the tobacco product or tobacco smoke. Nothing in this subparagraph shall be construed to limit the Secretary’s authority to take action under this section or other sections of this chapter applicable to menthol or any artificial or natural flavor, herb, or spice not specified in this subparagraph. (B) *Additional special rule* — Beginning 2 years after June 22, 2009, a tobacco product manufacturer shall not use tobacco, including foreign grown tobacco, that contains a pesticide chemical residue that is at a level greater than is specified by any tolerance applicable under Federal law to domestically grown tobacco. (2) **Revision of tobacco product standards** — The Secretary may revise the tobacco product standards in paragraph (1) in accordance with subsection (c). (3) **Tobacco product standards** (A) *In general* — The Secretary may adopt tobacco product standards in addition to those in paragraph (1) if the Secretary finds that a tobacco product standard is appropriate for the protection of the public health. (B) *Determinations* (i) *Considerations* — In making a finding described in subparagraph (A), the Secretary shall consider scientific evidence concerning— (I) the risks and benefits to the population as a whole,

Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 387g

Stored review status: release_metadata_unconfirmed. Explicit cross-reference supplied in source Markdown; currentness and applicability require review.

Federal law — U.S. Code and appendices · legal_authorities

21 U.S.C. § 321 — Definitions; generally

For the purposes of this chapter— **(a)** (1) The term “State”, except as used in the last sentence of [section 372(a) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section372/a&num=0&edition=prelim), means any State or Territory of the United States, the District of Columbia, and the Commonwealth of Puerto Rico. (2) The term “Territory” means any Territory or possession of the United States, including the District of Columbia, and excluding the Commonwealth of Puerto Rico and the Canal Zone. **(b)** The term “interstate commerce” means (1) commerce between any State or Territory and any place outside thereof, and (2) commerce within the District of Columbia or within any other Territory not organized with a legislative body. **(c)** The term “Department” means Department of Health and Human Services. **(d)** The term “Secretary” means the Secretary of Health and Human Services. **(e)** The term “person” includes individual, partnership, corporation, and association. **(f)** The term “food” means (1) articles used for food or drink for man or other animals, (2) chewing gum, and (3) articles used for components of any such article. **(g)** (1) The term “drug” means (A) articles recognized in the official United States Pharmacopoeia,11 So in original. Probably should be “Pharmacopeia,”. official Homoeopathic Pharmacopoeia of the United States, or official National Formulary, or any supplement to any of them; and (B) articles intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in man or other animals; and (C) articles (other than food) intended to affect the structure or any function of the body of man or other animals; and (D) articles intended for use as a component of any article specif

Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 321

Stored review status: release_metadata_unconfirmed. Explicit cross-reference supplied in source Markdown; currentness and applicability require review.

Federal law — U.S. Code and appendices · legal_authorities

21 U.S.C. § 387i — Records and reports on tobacco products

**(a) In general** Every person who is a tobacco product manufacturer or importer of a tobacco product shall establish and maintain such records, make such reports, and provide such information, as the Secretary may by regulation reasonably require to assure that such tobacco product is not adulterated or misbranded and to otherwise protect public health. Regulations prescribed under the preceding sentence— (1) may require a tobacco product manufacturer or importer to report to the Secretary whenever the manufacturer or importer receives or otherwise becomes aware of information that reasonably suggests that one of its marketed tobacco products may have caused or contributed to a serious unexpected adverse experience associated with the use of the product or any significant increase in the frequency of a serious, expected adverse product experience; (2) shall require reporting of other significant adverse tobacco product experiences as determined by the Secretary to be necessary to be reported; (3) shall not impose requirements unduly burdensome to a tobacco product manufacturer or importer, taking into account the cost of complying with such requirements and the need for the protection of the public health and the implementation of this subchapter; (4) when prescribing the procedure for making requests for reports or information, shall require that each request made under such regulations for submission of a report or information to the Secretary state the reason or purpose for such request and identify to the fullest extent practicable such report or information; (5) when requiring submission of a report or information to the Secretary, shall state the reason or purpose for the submission of such report or information and identify to the fullest extent practicabl

Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 387i

Stored review status: release_metadata_unconfirmed. Explicit cross-reference supplied in source Markdown; currentness and applicability require review.

Federal law — U.S. Code and appendices · legal_authorities

21 U.S.C. § 374 — Inspection

**(a) Right of agents to enter; scope of inspection; notice; promptness; exclusions** (1) For purposes of enforcement of this chapter, officers or employees duly designated by the Secretary, upon presenting appropriate credentials and a written notice to the owner, operator, or agent in charge, are authorized (A) to enter, at reasonable times, any factory, warehouse, or establishment in which food, drugs, devices, tobacco products, or cosmetics are manufactured, processed, packed, or held, for introduction into interstate commerce or after such introduction, or to enter any vehicle being used to transport or hold such food, drugs, devices, tobacco products, or cosmetics in interstate commerce; and (B) to inspect, at reasonable times and within reasonable limits and in a reasonable manner, such factory, warehouse, establishment, or vehicle and all pertinent equipment, finished and unfinished materials, containers, and labeling therein. In the case of any person (excluding farms and restaurants) who manufactures, processes, packs, transports, distributes, holds, or imports foods, the inspection shall extend to all records and other information described in [section 350c of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section350c&num=0&edition=prelim), when the standard for records inspection under paragraph (1) or (2) of [section 350c(a) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section350c/a&num=0&edition=prelim) applies, subject to the limitations established in [section 350c(d) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section350c/d&num=0&edition=prelim). In the case of a facility (as defined in [section 364 of this title](https://uscode.house.gov/vi

Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 374

Stored review status: release_metadata_unconfirmed. Explicit cross-reference supplied in source Markdown; currentness and applicability require review.

Federal law — U.S. Code and appendices · legal_authorities

21 U.S.C. § 387e — Annual registration

**(a) Definitions** In this section: (1) **Manufacture, preparation, compounding, or processing** — The term “manufacture, preparation, compounding, or processing” shall include repackaging or otherwise changing the container, wrapper, or labeling of any tobacco product package in furtherance of the distribution of the tobacco product from the original place of manufacture to the person who makes final delivery or sale to the ultimate consumer or user. (2) **Name** — The term “name” shall include in the case of a partnership the name of each partner and, in the case of a corporation, the name of each corporate officer and director, and the State of incorporation. **(b) Registration by owners and operators** On or before December 31 of each year, every person who owns or operates any establishment in any State engaged in the manufacture, preparation, compounding, or processing of a tobacco product or tobacco products shall register with the Secretary the name, places of business, and all such establishments of that person. If enactment of the Family Smoking Prevention and Tobacco Control Act occurs in the second half of the calendar year, the Secretary shall designate a date no later than 6 months into the subsequent calendar year by which registration pursuant to this subsection shall occur. **(c) Registration by new owners and operators** Every person upon first engaging in the manufacture, preparation, compounding, or processing of a tobacco product or tobacco products in any establishment owned or operated in any State by that person shall immediately register with the Secretary that person’s name, place of business, and such establishment. **(d) Registration of added establishments** Every person required to register under subsection (b) or (c) shall immediatel

Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 387e

Stored review status: release_metadata_unconfirmed. Explicit cross-reference supplied in source Markdown; currentness and applicability require review.

Federal law — U.S. Code and appendices · legal_authorities

21 U.S.C. § 387f — General provisions respecting control of tobacco products

**(a) In general** Any requirement established by or under section 387b, 387c, 387e, or 387i of this title applicable to a tobacco product shall apply to such tobacco product until the applicability of the requirement to the tobacco product has been changed by action taken under [section 387g of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section387g&num=0&edition=prelim), [section 387j of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section387j&num=0&edition=prelim), [section 387k of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section387k&num=0&edition=prelim), or subsection (d) of this section, and any requirement established by or under section 387b, 387c, 387e, or 387i of this title which is inconsistent with a requirement imposed on such tobacco product under [section 387g of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section387g&num=0&edition=prelim), [section 387j of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section387j&num=0&edition=prelim), [section 387k of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section387k&num=0&edition=prelim), or subsection (d) of this section shall not apply to such tobacco product. **(b) Information on public access and comment** Each notice of proposed rulemaking or other notification under section 387g, 387h, 387i, 387j, or 387k of this title or under this section, any other notice which is published in the Federal Register with respect to any other action taken under any such section and which states the reasons for such action, and each publication of findings required to be made in connection with rulemaking

Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 387f

Stored review status: release_metadata_unconfirmed. Incoming connection: Explicit cross-reference supplied in source Markdown; currentness and applicability require review.

Federal law — U.S. Code and appendices · legal_authorities

21 U.S.C. § 387k — Modified risk tobacco products

**(a) In general** No person may introduce or deliver for introduction into interstate commerce any modified risk tobacco product unless an order issued pursuant to subsection (g) is effective with respect to such product. **(b) Definitions** In this section: (1) **Modified risk tobacco product** — The term “modified risk tobacco product” means any tobacco product that is sold or distributed for use to reduce harm or the risk of tobacco-related disease associated with commercially marketed tobacco products. (2) **Sold or distributed** (A) *In general* — With respect to a tobacco product, the term “sold or distributed for use to reduce harm or the risk of tobacco-related disease associated with commercially marketed tobacco products” means a tobacco product— (i) the label, labeling, or advertising of which represents explicitly or implicitly that— (I) the tobacco product presents a lower risk of tobacco-related disease or is less harmful than one or more other commercially marketed tobacco products; (II) the tobacco product or its smoke contains a reduced level of a substance or presents a reduced exposure to a substance; or (III) the tobacco product or its smoke does not contain or is free of a substance; (ii) the label, labeling, or advertising of which uses the descriptors “light”, “mild”, or “low” or similar descriptors; or (iii) the tobacco product manufacturer of which has taken any action directed to consumers through the media or otherwise, other than by means of the tobacco product’s label, labeling, or advertising, after June 22, 2009, respecting the product that would be reasonably expected to result in consumers believing that the tobacco product or its smoke may present a lower risk of disease or is less harmful than

Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 387k

Stored review status: release_metadata_unconfirmed. Incoming connection: Explicit cross-reference supplied in source Markdown; currentness and applicability require review.

Federal law — U.S. Code and appendices · legal_authorities

21 U.S.C. § 387u — Studies of progress and effectiveness

**(a) FDA report** Not later than 3 years after June 22, 2009, and not less than every 2 years thereafter, the Secretary of Health and Human Services shall submit to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives, a report concerning— (1) the progress of the Food and Drug Administration in implementing this division, including major accomplishments, objective measurements of progress, and the identification of any areas that have not been fully implemented; (2) impediments identified by the Food and Drug Administration to progress in implementing this division and to meeting statutory timeframes; (3) data on the number of new product applications received under [section 387j of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section387j&num=0&edition=prelim) and modified risk product applications received under [section 387k of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section387k&num=0&edition=prelim), and the number of applications acted on under each category; and (4) data on the number of full time equivalents engaged in implementing this division. **(b) GAO report** Not later than 5 years after June 22, 2009, the Comptroller General of the United States shall conduct a study of, and submit to the Committees described in subsection (a) a report concerning— (1) the adequacy of the authority and resources provided to the Secretary of Health and Human Services for this division to carry out its goals and purposes; and (2) any recommendations for strengthening that authority to more effectively protect the public health with respect to the manufacture, marketing, and distribution of tobacco product

Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 387u

Stored review status: release_metadata_unconfirmed. Incoming connection: Explicit cross-reference supplied in source Markdown; currentness and applicability require review.

Federal law — U.S. Code and appendices · legal_authorities

21 U.S.C. § 387v — Reporting on tobacco regulation activities

**(a) In general** For fiscal year 2022 and each subsequent fiscal year for which fees are collected under [section 387s of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section387s&num=0&edition=prelim), the Secretary of Health and Human Services shall, not later than 180 days after the end of the fiscal year, prepare and submit to the Committee on Energy and Commerce and the Committee on Appropriations of the House of Representatives, and the Committee on Health, Education, Labor, and Pensions and the Committee on Appropriations of the Senate, an annual report that contains the information required under subsection (b). **(b) Required information** Each report submitted under subsection (a) shall contain the following information for the previous fiscal year: (1) Total annual user fee collections. (2) Total amount of fees obligated. (3) The amount of unobligated carryover balance from fees collected. (4) The amount obligated by the Center for Tobacco Products for each of the following activities: (A) Compliance and enforcement. (B) Public education campaigns. (C) Scientific research and research infrastructure. (D) Communications. (E) Leadership, management oversight, and administrative services. (F) Related overhead activities. (5) The numbers of applications, categorized by class of tobacco product and review pathway under sections 387e, 387j, and 387k of this title, that were— (A) submitted; (B) pending; (C) accepted; (D) refused to file; (E) withdrawn; (F) denied; (G) authorized for marketing under an order; (H) issued a deficiency letter or environmental information request letter; or (I) referred to the Tobacco Products Scientific Advisory Committee. (6) The number and titles

Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 387v

Stored review status: release_metadata_unconfirmed. Incoming connection: Explicit cross-reference supplied in source Markdown; currentness and applicability require review.